FDA.reportPublic FDA data

lanreotide 60 MG in 0.2 ML Prefilled Syringe

RxCUI
749811
RxNorm name
lanreotide 60 MG in 0.2 ML Prefilled Syringe
Display name
lanreotide 60 MG in 0.2 ML Prefilled Syringe
Full name
lanreotide 60 MG in 0.2 ML Prefilled Syringe
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LANREOTIDE ACETATELANREOTIDE ACETATEEXELAN PHARMACEUTICALS, INC.eec3c37e-83a7-4195-bccf-cd5973459eef2025-02-01Warnings, Adverse reactionsExact identifier
rxcui: 749811
LANREOTIDE ACETATELANREOTIDE ACETATECipla USA Inc.2892b4c3-0329-4d29-97ff-3b45283bbab12025-02-01Warnings, Adverse reactionsExact identifier
rxcui: 749811
SOMATULINE DEPOTLANREOTIDE ACETATEIpsen Biopharmaceuticals, Inc.6e4a41fd-a753-4362-87ee-8cc56ed3660d2024-10-11Warnings, Adverse reactionsExact identifier
rxcui: 749811
Lanreotide AcetateLANREOTIDE ACETATECipla USA Inc.11da176a-99bc-4ada-8b3f-6bd2b37a63132024-09-01Warnings, Adverse reactionsExact identifier
rxcui: 749811

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 4 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
6e4a41fd-a753-4362-87ee-8cc56ed3660dlanreotide 60 MG in 0.2 ML Prefilled Syringe [PSN] · 0.2 ML lanreotide 300 MG/ML Prefilled Syringe [SCD] · lanreotide 60 MG per 0.2 ML (as lanreotide acetate) Prefilled Syringe [SY]316These highlights do not include all the information needed to use SOMATULINE DEPOT safely and effectively. See full prescribing information for SOMATULINE DEPOT. SOMATULINE ® DEPOT (lanreotide) injection, for subcutaneous use Initial U.S. Approval: 200720241011
11da176a-99bc-4ada-8b3f-6bd2b37a6313lanreotide 60 MG in 0.2 ML Prefilled Syringe [PSN] · 0.2 ML lanreotide 300 MG/ML Prefilled Syringe [SCD] · lanreotide 60 MG per 0.2 ML (as lanreotide acetate) Prefilled Syringe [SY]37These highlights do not include all the information needed to use LANREOTIDE INJECTION safely and effectively. See full prescribing information for LANREOTIDE INJECTION. LANREOTIDE injection, for subcutaneous use Initial U.S. Approval: 200720240901
2892b4c3-0329-4d29-97ff-3b45283bbab1lanreotide 60 MG in 0.2 ML Prefilled Syringe [PSN] · 0.2 ML lanreotide 300 MG/ML Prefilled Syringe [SCD] · lanreotide 60 MG per 0.2 ML (as lanreotide acetate) Prefilled Syringe [SY]33These highlights do not include all the information needed to use LANREOTIDE INJECTION safely and effectively. See full prescribing information for LANREOTIDE INJECTION. LANREOTIDE injection, for subcutaneous use Initial U.S. Approval: 200720250201
eec3c37e-83a7-4195-bccf-cd5973459eeflanreotide 60 MG in 0.2 ML Prefilled Syringe [PSN] · 0.2 ML lanreotide 300 MG/ML Prefilled Syringe [SCD] · lanreotide 60 MG per 0.2 ML (as lanreotide acetate) Prefilled Syringe [SY]32These highlights do not include all the information needed to use LANREOTIDE INJECTION safely and effectively. See full prescribing information for LANREOTIDE INJECTION. LANREOTIDE injection, for subcutaneous use Initial U.S. Approval: 200720250201